Then, the correlation between the expression levels of USP29 and the clinical characteristics of CRC patients was analyzed, and it was found that USP29 expression level was correlated to tumor size, lymph node metastasis, and TNM stage of CRC patients (Table 2). This evidence concerns the gene USP29 and neoplasm.